Atlas Trials

Phase IIa Study of Multiple Doses of AbGn-168H by iv Infusion in Moderate to Severe Chronic Plaque Psoriasis Patients

Clinical trial NCT01855880 · COMPLETED

Trial details

NCT number
NCT01855880
Sponsor
AbGenomics B.V Taiwan Branch
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Moderate to Severe Chronic Plaque Psoriasis
Start date
2013-05-01
Primary completion
2014-02-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.